Bristol-Myers Squibb Recalls Eliquis 5mg Tablets Due to Labeling Error
Bristol-Myers Squibb is recalling 48,180 bottles of Eliquis 5mg tablets because one bottle was found to contain 2.5mg tablets instead.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a minimum score of 4 (Severe).
Plain-English summary
Bristol-Myers Squibb Company is recalling 48,180 bottles of Eliquis 5mg tablets, 60-count bottles, NDC 0003-0894-21. The recall is due to a labeling error where one bottle was found to contain lower-strength Eliquis 2.5mg tablets instead of the labeled 5mg tablets.
The affected product is identified by Lot HN0063 with an expiration date of 09/2019. The product was distributed nationwide in the US.
Consumers should check their medication for this specific lot number and expiration date. If they have the affected product, they should stop using it and contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
- Manufacturer
- Bristol-myers Squibb Company
- Category
- Drug — Anticoagulant
- Affected units
- 48,180
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: HN0063
- EXP. 09/2019
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Bristol-myers Squibb Company
See all →- HighOpdualag injection vials recalled from one lot over sterility assurance
FDA (Drugs) · 2025-10-29
- SevereBristol-Myers Squibb Recalls BiCNU Injection Kits Due to Overfilled Vials
FDA (Drugs) · 2012-10-31
- ModerateBristol-Myers Squibb Recalls Mislabelled Kombiglyze XR Physician Sample Cartons
FDA (Drugs) · 2012-10-31
- ModerateBristol-Myers Squibb Recalls Mispackaged Kombiglyze XR Physician Sample Cartons
FDA (Drugs) · 2012-10-31
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02